Literature DB >> 1107514

Pharmacokinetics and clinical use of cephalosporin antibiotics.

C H Nightingale, D S Greene, R Quintiliani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1107514     DOI: 10.1002/jps.2600641202

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  55 in total

1.  Protein binding of cefazolin is saturable in vivo both between and within patients.

Authors:  Jane W A Vella-Brincat; Evan J Begg; Carl M J Kirkpatrick; Mei Zhang; Stephen T Chambers; Kate Gallagher
Journal:  Br J Clin Pharmacol       Date:  2007-01-12       Impact factor: 4.335

2.  Comparative pharmacokinetics of cefamandole, cephapirin, and cephalothin in healthy subjects and effect of repeated dosing.

Authors:  M Barza; S Melethil; S Berger; E C Ernst
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

3.  Comparative pharmacology of cefaclor and cephalexin.

Authors:  O M Korzeniowski; W M Scheld; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

4.  Fluorimetric assay of cephradine, cephalexin and cephaloglycin.

Authors:  R H Barbhaiya; P Turner
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

5.  Faropenem transport across the renal epithelial luminal membrane via inorganic phosphate transporter Npt1.

Authors:  H Uchino; I Tamai; H Yabuuchi; K China; K Miyamoto; E Takeda; A Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

6.  Pharmacokinetics of cefotetan in normal subjects and patients with impaired renal function.

Authors:  M Ohkawa; S Hirano; S Tokunaga; I Motoi; R Shoda; A Ikeda; T Sugata; M Sawaki; M Shimamura; A Okasho; K Kuroda
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

7.  Dose linearity testing of intravenous cefpirome (HR 810), a novel cephalosporin derivate.

Authors:  L Maass; V Malerczyk; M Verho; P Hajdú; K Seeger; N Klesel
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

8.  Pharmacokinetics of cefroxadin (CGP 9000) in man.

Authors:  A Gerardin; J B Lecaillon; J P Schoeller; G Humbert; J Guibert
Journal:  J Pharmacokinet Biopharm       Date:  1982-02

9.  Pharmacokinetics of cefamandole in the presence of renal failure in patients undergoing hemodialysis.

Authors:  G B Appel; H C Neu; M F Parry; M J Goldberger; G B Jacob
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

10.  Pharmacokinetics of cefaclor and cephalexin: dosage nomograms for impaired renal function.

Authors:  D A Spyker; B L Thomas; M A Sande; W K Bolton
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.